Cibc Private Wealth Group, LLC Reata Pharmaceuticals Inc Transaction History

Cibc Private Wealth Group, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$78.27 - $151.29 $2.31 Million - $4.46 Million	-29,496 Closed	0 $0
Q1 2021 May 12, 2021	BUY	$94.25 - $132.81 $31,385 - $44,225	333 Added 1.14%	29,496 $2.94 Million
Q4 2020 Feb 12, 2021	BUY	$102.03 - $184.62 $1.5 Million - $2.71 Million	14,664 Added 101.14%	29,163 $3.61 Million
Q3 2020 Nov 03, 2020	BUY	$93.53 - $163.34 $1.36 Million - $2.37 Million	14,499 New	14,499 $1.41 Million
Q2 2018 Aug 02, 2018	SELL	$19.94 - $40.96 $251,064 - $515,727	-12,591 Closed	0 $0
Q2 2017 Aug 09, 2017	BUY	N/A	12,591	12,591 $398,000

62.7K

Ticker RETA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,583,200
Description
Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney diseas...

Get notified when there are updates to the investment portfolio of Cibc Private Wealth Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Cibc Private Wealth Group, LLC with notifications on news.